公司资料
Northwest Biotherapeutics 股价、新闻与催化剂
- 股票代码:
- NWBO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.16 USD (-3.26%)
收盘价
最后更新: 2026年9月18日
—
市值
股价为何变动
截至 2026年9月18日，NWBO 下跌 3.26%，收于 $0.1601。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Northwest Biotherapeutics is an immunotherapy company focused on cancer vaccines and personalized tumor treatment. Its business has been shaped by a long-duration and highly controversial development story.
所在地与行业分类
Headquartered in the United States and listed on OTC markets, Northwest sits in oncology biotechnology.
商业模式特征
The company depends on clinical validation, regulatory progress, and the ability to convert vaccine science into value.
生物医药行业定位
Northwest is a highly speculative oncology name whose valuation is driven by high-uncertainty clinical outcomes.
未来催化剂
- Northwest Biotherapeutics’s catalyst is DCVax-L and any regulatory or commercial update that clarifies whether the long-running glioblastoma story still has a path. The stock remains heavily event-driven.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。